Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Bio-Matrix Scientific Group Inc (BMSN)

Bio-Matrix Scientific Group Inc (BMSN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Bio-Matrix Scientific Group Inc

Description:

Bio-Matrix Scientific Group, Inc., was organized October 6, 1998, under the laws of the State of Delaware as Tasco International, Inc. It is in the development stage. The Company intends to engage mainly in: providing biospecimen depository services, namely offering cryopreservation of cellular specimens as well as laboratory processing of cellular specimens and through Entest, its majority owned subsidiary, developing and commercializing therapies, medical devices and medical testing procedures. Biospecimen depository services are intended to be provided at its 14,562 sq. ft. facility. The facility houses two secure cryogenic stem cell banks, three research laboratories, and aseptic cellular/tissue class 10,000/100 processing lab as well as hematology, microbiology and flow cytometry laboratories. Entest intends to develop and commercialize therapies, medical devices and medical testing procedures. The current strategy of Entest is to license intellectual property (IP) for development and commercialization by Entest and fund the development of internally developed IP through obtaining of grants from governmental and other entities. The industries in which it intends to compete are highly competitive.

Key Statistics

Overview:

Annual Sales, $ 0 K
Annual Net Income, $ 0 K

Growth:

1-Year Return 30.00%
3-Year Return -35.00%
5-Year Return -67.50%

Per-Share Information:

Latest Earnings Date N/A
Dividend Payout Ratio 0.00%

BMSN Ratios

Ratio
Price/Earnings ttm N/A
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % N/A
Return-on-Assets % N/A
Profit Margin % 0.00%
Debt/Equity N/A
Price/Sales N/A
Price/Cash Flow N/A
Price/Book N/A
Book Value/Share N/A
Interest Coverage N/A
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar